MAYA MARTINEZ-DAVIS was appointed global head of the oncology franchise of Merck KGaA. She will be based in Billerica, Mass., and will report to Rehan Verjee, chief marketing and strategy officer of the healthcare business sector. Martinez-Davis was a senior executive with Pfizer for more than a decade. Prior to her tenure with Pfizer, she...
The FDA Oncologic Drugs Advisory Committee July 25 voted unanimously to set more rigorous standards for new trials for approval of perioperative indications of cancer drugs.
